162 related articles for article (PubMed ID: 17361977)
1. Nonphosphate inhibitors of IspE protein, a kinase in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antimalarial therapy.
Hirsch AK; Lauw S; Gersbach P; Schweizer WB; Rohdich F; Eisenreich W; Bacher A; Diederich F
ChemMedChem; 2007 Jun; 2(6):806-10. PubMed ID: 17361977
[No Abstract] [Full Text] [Related]
2. Synthesis and characterization of cytidine derivatives that inhibit the kinase IspE of the non-mevalonate pathway for isoprenoid biosynthesis.
Crane CM; Hirsch AK; Alphey MS; Sgraja T; Lauw S; Illarionova V; Rohdich F; Eisenreich W; Hunter WN; Bacher A; Diederich F
ChemMedChem; 2008 Jan; 3(1):91-101. PubMed ID: 18033714
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent inhibitors for IspF, an enzyme in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antimalarial therapy.
Crane CM; Kaiser J; Ramsden NL; Lauw S; Rohdich F; Eisenreich W; Hunter WN; Bacher A; Diederich F
Angew Chem Int Ed Engl; 2006 Feb; 45(7):1069-74. PubMed ID: 16392111
[No Abstract] [Full Text] [Related]
4. Streptococcus pneumoniae isoprenoid biosynthesis is downregulated by diphosphomevalonate: an antimicrobial target.
Andreassi JL; Dabovic K; Leyh TS
Biochemistry; 2004 Dec; 43(51):16461-6. PubMed ID: 15610040
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional inhibitors of mevalonate kinase and mevalonate 5-diphosphate decarboxylase.
Qiu Y; Li D
Org Lett; 2006 Mar; 8(6):1013-6. PubMed ID: 16524256
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of the kinase IspE: structure-activity relationships and co-crystal structure analysis.
Hirsch AK; Alphey MS; Lauw S; Seet M; Barandun L; Eisenreich W; Rohdich F; Hunter WN; Bacher A; Diederich F
Org Biomol Chem; 2008 Aug; 6(15):2719-30. PubMed ID: 18633530
[TBL] [Abstract][Full Text] [Related]
7. Nonmevalonate terpene biosynthesis enzymes as antiinfective drug targets: substrate synthesis and high-throughput screening methods.
Illarionova V; Kaiser J; Ostrozhenkova E; Bacher A; Fischer M; Eisenreich W; Rohdich F
J Org Chem; 2006 Nov; 71(23):8824-34. PubMed ID: 17081012
[TBL] [Abstract][Full Text] [Related]
8. Screening for mevalonate biosynthetic pathway inhibitors using sensitized bacterial strains.
Ferrand S; Tao J; Shen X; McGuire D; Schmid A; Glickman JF; Schopfer U
J Biomol Screen; 2011 Jul; 16(6):637-46. PubMed ID: 21593486
[TBL] [Abstract][Full Text] [Related]
9. Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.
Kuntz L; Tritsch D; Grosdemange-Billiard C; Hemmerlin A; Willem A; Bach TJ; Rohmer M
Biochem J; 2005 Feb; 386(Pt 1):127-35. PubMed ID: 15473867
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of chloroplastidic and extrachloroplastidic terpenoids in liverwort cultured cells: 13C serine as a probe of terpene biosynthesis via mevalonate and non-mevalonate pathways.
Itoh D; Kawano K; Nabeta K
J Nat Prod; 2003 Mar; 66(3):332-6. PubMed ID: 12662088
[TBL] [Abstract][Full Text] [Related]
11. A role for geranylgeranylation in interleukin-1beta secretion.
Mandey SH; Kuijk LM; Frenkel J; Waterham HR
Arthritis Rheum; 2006 Nov; 54(11):3690-5. PubMed ID: 17075828
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase, an enzyme in the non-mevalonate pathway of isoprenoid synthesis.
Wada T; Kuzuyama T; Satoh S; Kuramitsu S; Yokoyama S; Unzai S; Tame JR; Park SY
J Biol Chem; 2003 Aug; 278(32):30022-7. PubMed ID: 12771135
[TBL] [Abstract][Full Text] [Related]
13. The identification of isoprenoids that bind in the intersubunit cavity of Escherichia coli 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase by complementary biophysical methods.
Kemp LE; Alphey MS; Bond CS; Ferguson MA; Hecht S; Bacher A; Eisenreich W; Rohdich F; Hunter WN
Acta Crystallogr D Biol Crystallogr; 2005 Jan; 61(Pt 1):45-52. PubMed ID: 15608374
[TBL] [Abstract][Full Text] [Related]
14. The isoprenoid-precursor dependence of Plasmodium spp.
van der Meer JY; Hirsch AK
Nat Prod Rep; 2012 Jul; 29(7):721-8. PubMed ID: 22555616
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of the isoprenoid moieties of furanonaphthoquinone I and endophenazine A in Streptomyces cinnamonensis DSM 1042.
Bringmann G; Haagen Y; Gulder TA; Gulder T; Heide L
J Org Chem; 2007 May; 72(11):4198-204. PubMed ID: 17474781
[TBL] [Abstract][Full Text] [Related]
16. Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways.
Hinson DD; Chambliss KL; Toth MJ; Tanaka RD; Gibson KM
J Lipid Res; 1997 Nov; 38(11):2216-23. PubMed ID: 9392419
[TBL] [Abstract][Full Text] [Related]
17. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
[TBL] [Abstract][Full Text] [Related]
18. [Interrelation between the pathways of isoprenoid biosynthesis and carbon source catabolism in anaerobic and facultatively anaerobic bacteria].
Trutko SM; Shcherbakova VA; Ivanova IV; Lysanskaia VIa; Arkhipova OV; Chuvil'skaia NA; Baskunov BP; Ostrovskiĭ DN; Akimenko VK
Mikrobiologiia; 2008; 77(3):303-10. PubMed ID: 18683645
[TBL] [Abstract][Full Text] [Related]
19. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids.
Martin VJ; Pitera DJ; Withers ST; Newman JD; Keasling JD
Nat Biotechnol; 2003 Jul; 21(7):796-802. PubMed ID: 12778056
[TBL] [Abstract][Full Text] [Related]
20. Coenzyme A biosynthesis: an antimicrobial drug target.
Spry C; Kirk K; Saliba KJ
FEMS Microbiol Rev; 2008 Jan; 32(1):56-106. PubMed ID: 18173393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
